Upmc Presbyterian Shadyside

UPMC Presbyterian Shadyside Presbyterian Campus Division, a non-profit academic medical center and division of the University of Pittsburgh Medical Center, operates as a prime contractor delivering specialized organ transplantation services and reference laboratory testing to the federal government under full-and-open competition with no set-aside designations. The organization is a child entity of UPMC, a major tax-exempt healthcare system headquartered in Pittsburgh, Pennsylvania, and competes as a direct healthcare provider rather than through intermediary subcontracting arrangements — 95% of its 176 recent federal awards are prime contracts.

The organization's federal customer base is heavily concentrated with the Department of Veterans Affairs (VA), which accounts for approximately 86 awards totaling $235.2 million in combined potential value, nearly all directed to Veterans Integrated Service Network 4 (VISN 4). This concentration reflects UPMC Presbyterian Shadyside's specialized role as a sole-source provider of organ transplantation services within the VA healthcare system. The customer footprint is otherwise sparse: Department of Health and Human Services Health Resources and Services Administration holds 8 to 6 awards depending on counting convention, and the Department of Justice Bureau of Prisons agencies (Hazleton, Elkton, Central Office, and US Marshals Service Western PA) account for approximately 12 combined awards valued at roughly $1 million. The top-customers-by-potential-value ranking aligns with the award-count ranking, surfacing no tension between frequency and dollar anchor.

UPMC Presbyterian Shadyside's capability portfolio centers on live donor liver transplant services, small bowel transplant services, and reference laboratory testing related to solid organ transplantation. Concrete examples include a $30.14 million single-award Indefinite Delivery/Indefinite Quantity contract with VA VISN 4 for small bowel transplant services (awarded August 1, 2021, extending through February 1, 2027) with recent delivery orders valued at $1.529 million (March 11, 2026), $1.348 million (September 24, 2024), and $809,000 (October 10, 2024); a $4.87 million indefinite-delivery vehicle for live donor liver transplant services under Executive Order 14042 (with recent orders ranging from $6,631 to $1.463 million and completing through November 2026); and a $7.124 million blanket purchase agreement for reference laboratory testing related to organ transplantation. Individual delivery orders consistently apply fixed-price with economic price adjustment pricing and carry no set-aside designation, reflecting the specialized and limited nature of these surgical and laboratory services. Performance locations include Pittsburgh, Sharpsburg, Arsenal, and Aspinwall, Pennsylvania, serving veterans throughout Western Pennsylvania and West Virginia.

Top parent vehicles for task-order activity include Indefinite Delivery Contract 36C24420D0064 (27 task orders, $8.3 million combined potential value), Indefinite Delivery Contract 36C24421D0092 (16 task orders, $7.9 million combined potential value), Indefinite Delivery Contract V646P2521 (7 task orders), Indefinite Delivery Contract V646P2459 (6 task orders), and Indefinite Delivery Contract VA24415D0477 (6 task orders, $5.2 million combined potential value).

Award activity has declined from peaks of 14 awards in 2022 and 16 in 2023 to 9 awards in 2025 and 1 award year-to-date in 2026, reflecting the project-based and delivery-order-driven nature of the customer base. Within the next twenty-four months, nine awards carrying combined potential value of $7.7 million are scheduled for ultimate completion, presenting recompete exposure primarily within the VA VISN 4 portfolio.

The organization operates as a direct healthcare provider with no named subcontractors across its identified federal contract awards. Service Contract Inventory data covering federal service contracts above the $150,000 threshold shows SCI-reportable invoiced revenue of $5.1 million across FY2022–FY2024, with FY2022 at $162 thousand (0.4 FTEs), FY2023 at $2 million (4.3 FTEs), and FY2024 at $2.9 million (6.4 FTEs). Government-paid hourly rates on SCI-reportable prime contracts ranged from a 10th percentile of $19.11/hr to a median of $128.79/hr to a 90th percentile of $256.55/hr. SCI records indicate zero average sub-hours share, confirming the vendor's posture as a direct service provider. The vendor also holds prime grants from the Health Resources and Services Administration's HIV/AIDS Bureau, including a $130.238 thousand Ryan White Title III HIV Capacity Development grant (awarded September 1, 2023, completing August 31, 2024) for gender-affirming HIV care innovation, and serves as a sub-recipient on federal grants from the Pennsylvania Department of Human Services and the Pennsylvania Department of Health for suicide prevention and poison information services.